About
Man-soon is an Executive Director and focuses on investments in healthcare and bio sectors. He is a licensed pharmacist who worked at KBIC Venture and Yuhan Corp's R&D center before he came to KIP in 2009. Man-soon also held Vice President positions at Chemon and Medi Flex, where he controlled all marketing and R&D activities. He leverages his hands-on experience running bio companies to help portfolio companies such as Eyegene and Viromed grow. Man-soon is the lead manager of KIP Global Pharma-Ecosystem Private Equity Fund (KRW 135bn) and serves as an adjunct professor at Konkuk University's School of Medicine. Man-soon holds his B.S. in Pharmaceutics and M.S. in Pharmacology from Seoul National University.
Position in the VCSift Database
- • 14 investors at Korea Investment Partners are tracked.
- • 658 investors hold the CEO role in VCSift. Man Soon Hwang is one of them.
- • 150 investors are based in South Korea.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- South Korea
Contact Information
Find more investors like Man Soon
Search Investors